Immunitybio Inc (IBRX) stock has gained 207.60% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives IBRX stock a score of 55 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 88. IBRX's rank also includes a short-term technical score of 75. IBRX has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on IBRX!